Workflow
合成生物学与绿色生物制造
icon
Search documents
花王、联合利华和欧莱雅共同押注初创,成功实现C12/C14脂肪醇替代品大规模生产!
【SynBioCon】 获 悉, Future O rigins 今 日宣布,其Nalo™大规模示范项目已成功完成。 Nalo™是一种零森林砍伐的直接替代品,可替代洗衣液 和洗面奶等表面活性剂中常用的C12/C14脂肪醇 。此次示范项目在综合精炼设施中生产了 超过10吨 符合规格的原料。 Future Origins是一家由工业生物技术领导者Geno公司与花王、联合利华和欧莱雅共同创立的美国合资企业,旨在实现家用和个人护理领域广泛使用的表 面活性剂原料的商业化和生产。 这次示范项目的成功被视为其首个商业规模制造工厂最终投资决策(FID)的重要一步。 Future Origins 首席执行官 John Gugel 表示 :"这项在综合精炼设施中 以数吨级规模 完成的示范活动,是从中试阶段迈向全面商业化生产的关键一步。这一重要 成就验证了我们产品的质量以及我们专有工艺技术的稳健性和可扩展性。在瞬息万变的市场中,消费品牌需要始终如一的卓越品质和稳定的供应链,而这正是 Future Origins 通过 Nalo 能够提供的。" /生物制造产业社群/ 让上下游聚在一起, 未来食农、绿色化工、大健康、美妆个护 等产业同 ...
这一酶技术,被嫌弃的秸秆,“身价”过亿了
Core Viewpoint - The article highlights the innovative "Three-Component Separation Technology" developed by Zhongnong Qimei, which transforms agricultural waste (straw) into high-value industrial products, addressing both resource utilization and environmental protection challenges in China [3][6][10]. Group 1: Technology Overview - Zhongnong Qimei's "Three-Component Separation Technology" was showcased at the 32nd China Yangling Agricultural High-Tech Achievements Expo, gaining significant attention [3][5]. - This technology allows for the complete decomposition of straw from nine major crops, converting it into pulp fibers, lyocell fibers, and soluble humic acid, achieving zero waste and low energy consumption [6][9]. - The technology integrates enzyme preparation, AI-enabled equipment systems, and smart process reconstruction, resulting in a 70% reduction in energy consumption and an 80% decrease in water usage [7][9]. Group 2: Market Potential and Trends - The annual collection of straw in China reaches 737 million tons, and the government supports the comprehensive utilization of straw as outlined in the 2025 Central Document No. 1 [5][10]. - The agricultural biotechnology sector is experiencing rapid growth, with synthetic biology projects receiving significant investment, indicating market recognition and capital interest [10][11]. - Zhongnong Qimei's dual-core product system of "bio-based fibers + humic acid" addresses the inefficiencies in straw utilization and opens new market opportunities, particularly in the paper industry [10][11]. Group 3: Strategic Collaborations and Future Plans - Strategic partnerships have been established with several companies, marking a transition from initial technology development to large-scale replication [13]. - Zhongnong Qimei plans to build multiple enzyme-based processing facilities across China during the 14th Five-Year Plan, aiming to process nearly 10 million tons of straw annually and expand its technology to regions rich in straw resources globally [13][15]. - The company aims to contribute to sustainable development by transforming straw from a burden into a valuable resource, showcasing the potential of new production capabilities in traditional agriculture [15].
破局 蝶变丨2025·第18届天俱时科技论坛圆满召开
主论坛由天俱时科技论坛组委会副主席,天津大学英才教授、博士生导师刘庆岭教授与天俱时科技 论坛组委会副主席,上海海嘉诺医药发展股份有限公司董事长张华博士共同主持。 图丨主持人刘庆岭(左)、张华(右)主持会议 01 开幕致辞:共绘产业创新蓝图 10月23日-24日,由天俱时科技论坛组委会与天俱时集团联合主办的"2025·第18届天俱时科技论 坛"(以下简称论坛),在石家庄中茂海悦酒店隆重举办。论坛以"破局 蝶变:共谋精细化工与合成生物产 业新篇"为主题,汇聚了近三百位来自国内外的知名专家学者、科研人员及企业代表,共赴一场科技与 创新的思想盛宴。 视频丨2025·第18届天俱时科技论坛盛况 天俱时科技论坛组委会副主席、天俱时首席技术官陈平博士致欢迎辞。陈平博士表示,当前精细化 工与合成生物产业正处在向高端化、智能化、绿色化转型的"攻坚深水区"。本届论坛以"破局·蝶变"为主 题,旨在汇聚产学研顶尖力量,共同探寻产业发展航向,期待通过论坛促成思维碰撞,转化为发展的实 际动能。 图丨陈平博士致欢迎辞 深圳市研一新材料有限责任公司董事长岳敏先生在致辞中表示,创新不能止于实验室,必须转化为 产业价值。他通过分享与天俱时合作打 ...
第一波大咖嘉宾揭晓!2025(第五届)非粮生物质高值化利用论坛将于11月杭州启程
聚焦非粮生物基领域创新科研成果和商业化可行性, DT新材料 将 联合 生物基运输燃料技术全国重点 实验室 将于 202 5 年 1 1 月 27-29 日 在 浙江 ·杭州 举办 " 202 5 (第 五 届)非粮生物质高值化 利用论坛 ( NFUCon 2025 ) ",以 为 " 顶尖智汇,产业共生 " 主题,将邀 约业界上下游代表性政 府园区、企业与专家,探讨 生物质绿色预处理、非粮糖、生物质基化学品和材料、生物质能(甲醇、 燃料乙醇、生物沼气、可持续航空燃料( SAF)) 等 重要战略方向,共同推动非粮生物质大规模应 用,助力实现双碳目标。 01 组织机构 主办单位 宁波德泰中研信息科技有限公司( DT新材料 ) 生物基运输燃料技术全国重点实验室 论坛共同主席 朱 锦 ,中国科学院宁波材料技术与工程研究所研究员、 浙江省 全省生物基高分子材料重点实验室 主任 李正龙 ,浙江大学求是讲席教授,国家级高层次人才,浙江省顶尖人才,生物基运输燃料技术全国重 点实验室生物航油负责人,浙江大学衢州研究院生物基化学品研究所所长 NFUCon 2025 2025(第五届)非粮生物质高值化利用论坛 11月27-29日 ...
西湖大学孙立成&曾安平院士团队将CO₂高效转化为PDO,BDO
/生物制造产业社群/ 让上下游聚在一起, 未来食农、绿色化工、大健康、美妆个护 等产业同行❤️↓ SynBio团队 | 西湖大学孙立成、曾安平 随着全球气候变化问题日益严峻,如何将 CO 2 高效转化为高附加值化学品已成为绿色化工与碳中和领 域的前沿课题。尽管电化学还原 CO 2 ( CO 2 RR )已能制备乙醇、乙烯等 C 2 化合物,但其在合成 更长碳链、更高价值的 C 3 -C 4 化合物(如 1,3- 丙二醇和 1,3- 丁二醇)方面仍面临效率低、选择性 差、产物单一等问题。传统生物法依赖葡萄糖或甘油发酵,虽可持续,但未能直接利用 CO 2 作为原 料。因此,开发一种 直接从 CO 2 出发、高效合成 C 3 -C 4 二醇 的新型技术路径,具有重要的科学意 义与产业价值。 【SynBioCon】 获 悉 , 近 日 , 孙立成教授 领导的 西湖大学人工光合作用与太阳能燃料中心 和 曾安平教授 领导的 合成生物学与生物智造中心 合作在 Journal of the American Chemical Society 期刊发表题为 "Ultrafast Conversion of CO 2 into ...
“以草代粮”新篇章!丰原集团平邑9万吨乳酸、6万吨聚乳酸、6万吨聚乳酸改性料项目公示
Core Insights - The article discusses the recent developments in the biomanufacturing industry, particularly focusing on projects related to lactic acid and polylactic acid production in Shandong province, China [2][3][4][5]. Project Developments - The Pingyi Fengyuan Lactic Acid Biotechnology Co., Ltd. is set to invest 60 million yuan in a project to produce 90,000 tons per year of lactic acid, utilizing straw sugar through fermentation and purification processes [3]. - The Pingyi Fengyuan Polylactic Acid Biotechnology Co., Ltd. plans to establish a project with a production capacity of 60,000 tons per year of polylactic acid, using lactic acid as a raw material [5]. - The Pingyi Polylactic Acid Modified Materials Co., Ltd. will invest 15 million yuan in a project to produce 60,000 tons per year of modified polylactic acid, with an expected completion date in January 2026 [6]. Production Capacity and Investment - The lactic acid project will have a production line capable of achieving an annual output of 90,000 tons, while the polylactic acid and modified materials projects will each reach 60,000 tons per year upon completion [3][5][6]. - The total investment for the modified materials project includes 1 million yuan allocated for environmental protection measures [6]. Industry Events - The Fifth Non-Grain Biomass High-Value Utilization Forum will focus on non-grain bio-based chemicals and materials, highlighting the industry's commitment to sustainable practices [9][10]. - The forum will feature various specialized sessions, including discussions on bio-based chemicals and materials, indicating a growing interest in the sector [13].
第一波大咖嘉宾揭晓!2025(第五届)非粮生物质高值化利用论坛将于11月杭州启程
NFUCon 2025 2025(第五届)非粮生物质高值化利用论坛 11月27-29日 浙江 ·杭州 聚焦非粮生物基领域创新科研成果和商业化可行性, DT新材料 将 联合 生物基运输燃料技术全国重点 实验室 将于 202 5 年 1 1 月 27-29 日 在 浙江 ·杭州 举办 " 202 5 (第 五 届)非粮生物质高值化 利用论坛 ( NFUCon 2025 ) ",以 为 " 顶尖智汇,产业共生 " 主题,将邀 约业界上下游代表性政 府园区、企业与专家,探讨 生物质绿色预处理、非粮糖、生物质基化学品和材料、生物质能(甲醇、 燃料乙醇、生物沼气、可持续航空燃料( SAF)) 等 重要战略方向,共同推动非粮生物质大规模应 用,助力实现双碳目标。 01 组织机构 主办单位 宁波德泰中研信息科技有限公司( DT新材料 ) 生物基运输燃料技术全国重点实验室 论坛共同主席 朱 锦 ,中国科学院宁波材料技术与工程研究所研究员、 浙江省 全省生物基高分子材料重点实验室 主任 李正龙 ,浙江大学求是讲席教授,国家级高层次人才,浙江省顶尖人才,生物基运输燃料技术全国重 点实验室生物航油负责人,浙江大学衢州研究院生物基化学 ...
生物制造,“十五五规划”未来10年, 中国如何再造一个高技术产业?
Core Viewpoint - The article emphasizes the significance of biomanufacturing as a key emerging industry in China's 14th Five-Year Plan, highlighting its potential to transform manufacturing, promote sustainability, and attract substantial capital investment [2][4][5]. Group 1: Importance of Biomanufacturing - Biomanufacturing is crucial for China's manufacturing transformation, serving as a new form of productive force that can empower various manufacturing sectors [4]. - It represents a sustainable and low-carbon industry direction, addressing China's deficiencies in oil and arable land [4]. - The biomanufacturing sector has the potential to become a massive new industry, with the U.S. planning a $30 trillion biomanufacturing market, equivalent to recreating the U.S. economy [5][6]. - This sector is expected to absorb vast amounts of capital, becoming a significant funding pool following the real estate bubble burst [5]. Group 2: Strategic Importance and Global Competition - Biomanufacturing is strategically as important as chip manufacturing, with projections indicating it could account for one-third of global manufacturing output by the end of the century [6]. - Countries are actively positioning themselves in biomanufacturing to avoid falling behind in future industrial competition [6]. - The U.S. has set a goal to replace 90% of traditional plastics with bio-based products within 20 years, while the EU plans to implement a carbon border adjustment mechanism by 2027, creating new trade barriers for high-carbon products from China [6][7]. Group 3: Challenges and Development Strategies - Despite holding 70% of global fermentation capacity, China's biomanufacturing industry faces challenges such as a lack of proprietary strains and limitations in core software tools [8]. - Mastering foundational technologies is critical for the development of China's biomanufacturing sector over the next decade [9]. - Key strategies include establishing high-level research platforms, promoting collaborative innovation between academia and industry, and enhancing market mechanisms to give enterprises a more significant role in research direction [9]. - There is a call for top-level design to focus on cutting-edge areas like CO2 bioconversion and future food manufacturing, aiming to address both green chemical alternatives and protein supply security [9].
IFF与巴斯夫两大巨头战略合作!加速酶技术在个人护理等应用
Core Viewpoint - BASF and IFF have formed a strategic partnership to accelerate the development of IFF's Designed Enzymatic Biomaterials™ (DEB) platform, focusing on high-performance, sustainable enzyme and bio-based polymer solutions for various applications, including fabric care, personal care, and industrial cleaning [2][6]. Group 1: Technological Collaboration - The DEB platform, launched in September, aims to commercialize unique polysaccharides that mimic natural components, replacing non-degradable ingredients in laundry formulations with bio-based solutions [5][6]. - The collaboration will expand the application of DEB technology into personal care, fabric washing, and industrial cleaning sectors [6]. Group 2: Innovation in Raw Materials Driven by Biotechnology - Enzymes are increasingly used in beauty and cleaning products, enhancing performance while reducing reliance on chemical ingredients, aligning with consumer demand for natural and eco-friendly products [6][7]. - In the beauty sector, enzymes facilitate biochemical reactions that improve skin conditions, with applications in exfoliation, antioxidant effects, anti-inflammation, whitening, and enhancing moisture retention [6][7]. Group 3: Market Trends and Growth - The anti-aging cosmetics market in China is projected to reach CNY 307.57 billion in 2024, growing by 17.2% year-on-year, while the whitening cosmetics market is expected to reach CNY 106.92 billion, with a growth rate of 6.0% [7]. - Recent advancements in biotechnology have led to the introduction of new bio-based raw materials, such as BASF's Verdessence Maize and Evonik's TEGOSOFT BC MB emulsifier, which significantly reduce carbon footprints compared to traditional chemical processes [9].
11个项目落地!钟楼合成生物 AI 赛道迎来新爆点
Core Insights - The article discusses the recent signing of key projects at the Changzhou Zhonglou Synthetic Biology AI Research Institute, focusing on addressing industry pain points and public health needs through innovative collaborations in synthetic biology and AI [2][4]. Project Progress - The signing ceremony highlighted 11 cutting-edge projects aimed at enhancing the high-quality development of the synthetic biology AI industry, covering platform cooperation, innovation incubation, and smart healthcare [2][4]. - Five platform cooperation projects were initiated to address industry capability gaps, including an "AI + Industry Integration Platform" by iFlytek and a focus on AI-enabled cell therapy for solid tumors by the Changzhou Xitaihu Cell Therapy Research Institute [4]. - Three innovation incubation projects aim to transition research outcomes into industry applications, such as the AI synthetic biology computing platform to reduce anti-tumor drug development costs [4]. Smart Healthcare Initiatives - Three smart healthcare projects were launched to tackle public health issues, including a synthetic biology functional food project and an AI smart rehabilitation therapy project [4]. - The initiatives aim to shift healthcare services from reactive treatment to proactive prevention, enhancing overall health management [4]. Expert Insights - Following the signing ceremony, experts discussed trends in "Biological Intelligent Manufacturing" and the intersection of artificial intelligence with synthetic biology, providing case studies to illustrate these developments [5].